IN2014DN07767A - - Google Patents

Info

Publication number
IN2014DN07767A
IN2014DN07767A IN7767DEN2014A IN2014DN07767A IN 2014DN07767 A IN2014DN07767 A IN 2014DN07767A IN 7767DEN2014 A IN7767DEN2014 A IN 7767DEN2014A IN 2014DN07767 A IN2014DN07767 A IN 2014DN07767A
Authority
IN
India
Prior art keywords
amino
salt
polyoxyethylene sorbitan
sorbitan fatty
fatty acid
Prior art date
Application number
Inventor
Takashi Morimoto
Hiroyuki Asada
Kyohei Takahashi
Tomoyuki Okamoto
Original Assignee
Santen Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Santen Pharmaceutical Co Ltd filed Critical Santen Pharmaceutical Co Ltd
Publication of IN2014DN07767A publication Critical patent/IN2014DN07767A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/196—Carboxylic acids, e.g. valproic acid having an amino group the amino group being directly attached to a ring, e.g. anthranilic acid, mefenamic acid, diclofenac, chlorambucil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/186—Quaternary ammonium compounds, e.g. benzalkonium chloride or cetrimide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Abstract

The present invention pertains t o an aqueous composition which contains 2 -amino - -(4 - Dromobenzoyl)phenvlacetic acid or a salt thereof and which may contain, if necessary, a benzalkonium chloride and/or a polyoxyethylene sorbitan fatty acid ester. The stability of 2-amino-3-(4-bromobenzoyl)phenylacetic acid or a salt thereof can be kept by restricting the contents of a benza -Ikonium chloride and a polyoxyethylene sorbitan fatty acid ester respectively within specific ranges, whereby a composition which does not suffer any appearance change can b e obtained.
IN7767DEN2014 2012-03-28 2013-03-28 IN2014DN07767A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2012073181 2012-03-28
PCT/JP2013/059211 WO2013147000A1 (en) 2012-03-28 2013-03-28 Aqueous composition containing 2-amino-3-(4-bromobenzoyl)- phenylacetic acid

Publications (1)

Publication Number Publication Date
IN2014DN07767A true IN2014DN07767A (en) 2015-05-15

Family

ID=49260248

Family Applications (1)

Application Number Title Priority Date Filing Date
IN7767DEN2014 IN2014DN07767A (en) 2012-03-28 2013-03-28

Country Status (9)

Country Link
JP (1) JP5922609B2 (en)
KR (1) KR20140139501A (en)
CN (1) CN104203224A (en)
IN (1) IN2014DN07767A (en)
MY (1) MY170840A (en)
PH (1) PH12014502171A1 (en)
SG (1) SG11201405837YA (en)
TW (1) TWI604858B (en)
WO (1) WO2013147000A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2016199854A1 (en) * 2015-06-10 2016-12-15 参天製薬株式会社 Ophthalmic solution and method for maintaining preservative efficacy of ophthalmic solution
WO2019117252A1 (en) * 2017-12-14 2019-06-20 参天製薬株式会社 Eye drop containing 2-amino-3-(4-bromobenzoyl) phenylacetic acid or salt thereof
CN114224830A (en) * 2021-12-24 2022-03-25 辰欣药业股份有限公司 Single-dose bacteriostatic-free ophthalmic preparation and preparation method thereof

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2002308764A (en) * 2001-02-09 2002-10-23 Taisho Pharmaceut Co Ltd Pharmaceutical composition for ophthalmic use
WO2005046700A1 (en) * 2003-11-14 2005-05-26 Senju Pharmaceutical Co., Ltd. Aqueous solution preparation containing aminoglycoside antibiotic and bromfenac
CN1823754A (en) * 2006-03-28 2006-08-30 卢秀莲 Sodium bromophenolate eye drops and its preparation method
CN101313899B (en) * 2007-06-01 2012-02-29 北京德众万全药物技术开发有限公司 Medicament composition for eyes containing sodium bromfenac
BRPI0908502A2 (en) * 2008-02-21 2017-05-23 Ista Pharmaceuticals ophthalmic aines as adjuvants
CN101322683B (en) * 2008-07-30 2013-01-16 浙江三叶药业有限公司 Gel for eye containing bromfenac sodium hydrate and preparation thereof
WO2012099142A1 (en) * 2011-01-18 2012-07-26 千寿製薬株式会社 Bromfenac aqueous liquid composition having preservative efficiency
JP6012231B2 (en) * 2011-04-08 2016-10-25 ロート製薬株式会社 Bromfenac-containing composition

Also Published As

Publication number Publication date
CN104203224A (en) 2014-12-10
JP5922609B2 (en) 2016-05-24
TW201343197A (en) 2013-11-01
JP2013227300A (en) 2013-11-07
PH12014502171A1 (en) 2014-12-10
KR20140139501A (en) 2014-12-05
MY170840A (en) 2019-09-10
SG11201405837YA (en) 2014-11-27
WO2013147000A1 (en) 2013-10-03
TWI604858B (en) 2017-11-11

Similar Documents

Publication Publication Date Title
PH12015502031B1 (en) Tetrahydropyrrolothiazine compounds
MX2016003843A (en) Irak inhibitors and uses thereof.
UY34763A (en) INHIBITORS OF THE PLAQUETARY AGGREGATION
EA201390074A1 (en) 5-HLOR-4-HYDROXY-1-METHIL-2-OXO-N-PHENYL-1,2-DIHYDROCHINOLIN-3-CARBOXAMID, ITS SALT AND APPLICATIONS
MX2015015421A (en) Acc inhibitors and uses thereof.
EP3046932A4 (en) Evolved sortases and uses thereof
MX2015015417A (en) Acc inhibitors and uses thereof.
MX351513B (en) 3,5-disubstituted alkynylbenzene compound and salt thereof.
MX361499B (en) Deuterated baricitinib.
UY34608A (en) SYNTHETIC PEPTIDES OF CHLOROPLAST TRANSIT.
MX336875B (en) Besylate salt of a btk inhibitor.
UY34721A (en) ANTI-HLA-B * 27 ANTIBODIES AND USES OF THESE.
MX2015011837A (en) Co-crystals of pyrimethanil and selected dithiine tetracarboximide.
NZ730790A (en) Composition of (6s)-5-methyl tetrahydrofolic acid or salt thereof as well as preparation therefor and application thereof
CA2875305C (en) Fbxo3 inhibitors
MX2015016332A (en) Pyrrolotriazines as alk inhibitors.
AU2014224814A8 (en) Novel halogen-substituted compounds
UA115072C2 (en) Hydantoin derivative
IN2014DN07767A (en)
MX370647B (en) Pharmaceutical formulation having improved stability.
CL2015002350A1 (en) Agrochemical composition in aqueous suspension
RS54689B1 (en) Fused bicyclic 2,4-diaminopyrimidine derivative as a dual alk and fak inhibitor
WO2013188789A3 (en) Genome-wide method of assessing interactions between chemical entities and their target molecules
BR112015021178A2 (en) fungicidal 3- {heterocyclyl [(heterocyclylmethoxy) imino] methyl} -oxadiazolone derivatives
HK1220393A1 (en) Aqueous composition containing stabilized 2-amino-3-(4- bromobenzoyl)phenylacetic acid 2--3-(4-)